Aranesp 100 MCG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQU1W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,716
Award facts
- Contract value 100% obligated
- $23,716.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,716 firm fixed-price delivery order to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) on January 12, 2026, for the supply of Aranesp 100 micrograms per 0.5 milliliter syringes. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of January 13, 2026, with performance to be executed at the awardee's location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999 and extending through December 2026.
AmerisourceBergen serves as a critical pharmaceutical distributor to federal medical procurement needs, particularly supporting military and veteran healthcare systems. The parent company, Cencora, Inc., holds the primary $999,999,999 IDC with the Defense Logistics Agency through December 2031, enabling comprehensive global pharmaceutical support across multiple therapeutic domains. The current delivery order for Aranesp, an erythropoiesis-stimulating agent used in treating anemia, exemplifies the company's role in supplying specialty medications and injectable pharmaceuticals to military treatment facilities and federal healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FQU1W?
SPE2DR26FQU1W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FQU1W worth?
The government has obligated $23,716 on SPE2DR26FQU1W.
Is contract SPE2DR26FQU1W an order under another contract?
Yes. SPE2DR26FQU1W is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU1W competed?
The extent of competition for SPE2DR26FQU1W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award